CureVac - Ingmar Hoerr, CEO

1,223 بار تماشا شده
8.1
ممنون، رأی شما ثبت شد و به‌زودی نمایش داده خواهد شد.
بله
نه
به نشانک‌های نمایه شما اضافه شد.
توضیحات ویدیو

CureVac, a clinical stage biopharmaceutical company from Tübingen, Germany, is pioneering the field of mRNA-based technology platforms for medical purposes with which mRNA is specifically optimised and formulated. Since 2000 the company develops novel mRNA-based cancer immunotherapies and prophylactic vaccines against infectious diseases – both under the brand RNActive®. CureVac has successfully established the first GMP (good manufacturing practice) facility worldwide for the manufacture of RNA and mRNA and has pioneered mRNA-based drugs in clinical studies.

اضافه شد در 29 مارس 2017
نظرات